Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 2.156 5-jähriger Impact-Faktor: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v22.i2.30
pages 109-116

Thymosin β4: A Potential Molecular Target for Tumor Therapy

Yongtao Xiao
Shanghai Institute of Pediatric Research, Shanghai, China;Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition,China
Yingwei Chen
Department of Gastroenterology, Shanghai Jiao Tong University, School of Medicine, Xin Hua Hospital, Shanghai, China;Shanghai Institute of Pediatric Research, Shanghai, China;Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition
Jie Wen
Shanghai Institute of Pediatric Research, Shanghai, China
Weihui Yan
Shanghai Institute of Pediatric Research, Shanghai, China
Kejun Zhou
Shanghai Institute of Pediatric Research, Shanghai, China;Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition,China
Wei Cai
Shanghai Institute of Pediatric Research, Shanghai, China ; Department of Pediatric Surgery, Shanghai Jiao Tong University, School of Medicine, Xin Hua Hospital, Shanghai, China

ABSTRAKT

Thymosin β4 (Tβ4), a 5 kDa protein, has been demonstrated to play an important role in a variety of biological activities, such as actin sequestering, cellular motility, migration, inflammation, and damage repair. Recently, several novel findings provided compelling evidence that Tβ4 played a key role in facilitating tumor metastasis and angiogenesis. It has been found that Tβ4 expressed increasingly in a number of metastatic tumors, which was associated with an increased expression of a known angiogenic factor, vascular endothelial growth factor. Thus, Tβ4 provided a potential target of opportunity for cancer management, especially for cancer metastasis therapy.


Articles with similar content:

The Ron Receptor Tyrosine Kinase: A Key Regulator of Inflammation and Cancer Progression
Critical Reviews™ in Immunology, Vol.33, 2013, issue 6
Pamela A. Hankey, Xin Wang
Checkpoint Modulators in Cancer Immunotherapy
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 1-2
Jean Sathish
Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 1
Carlos L. Arteaga, Brent N. Rexer
The Identification and Development of Specific Monoclonal Antibodies to Squamous Cell Carcinoma
Critical Reviews™ in Immunology, Vol.21, 2001, issue 1-3
Joyce Wolf, Joseph Scherrer, Myron Arlen, Al Tsang, Olga Saric
p120-CATENIN: A NOVEL REGULATOR OF INNATE IMMUNITY AND INFLAMMATION
Critical Reviews™ in Immunology, Vol.32, 2012, issue 2
Guochang Hu